Dr. Bradley Strauss obtained his MD from the University of Toronto in 1982
Dr. Bradley Strauss obtained his MD from the University of Toronto in 1982. He completed a Fellowship at the Thoraxcenter in Rotterdam under Professor Patrick Serruys. He was Chief of the Schulich Heart Program and Head of the Division of Cardiology at Sunnybrook Hospital in Toronto, Canada. He holds the Reichmann Chair in Cardiovascular Research. He has founded two companies, Matrizyme Pharma, to commercialize the use of collagenase in chronic total occlusions and RBY Medical for vascular catheters. He is one of the co-Founders of the Medventions Innovation Program at Sunnybrook.